CP 118

Drug Profile

CP 118

Alternative Names: COL 118; CP118

Latest Information Update: 20 Mar 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Collegium Pharmaceutical
  • Class Antihistamines
  • Mechanism of Action Histamine receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Allergic rhinitis

Most Recent Events

  • 20 Mar 2014 Discontinued - Phase-II for Allergic rhinitis in USA (PO)
  • 27 May 2009 Efficacy data from a phase II trial in Allergic rhinitis released by Collegium
  • 07 Mar 2007 Results from a phase II clinical trial in patients with Allergic rhinitis have been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top